Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
$460M |
| 2 |
GE Aerospace
GE
|
$402M |
| 3 |
CELG
Celgene Corp
CELG
|
$381M |
| 4 |
Bristol-Myers Squibb
BMY
|
$379M |
| 5 |
Johnson & Johnson
JNJ
|
$358M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$307M |
| 2 |
Costco
COST
|
$279M |
| 3 |
Lowe's Companies
LOW
|
$273M |
| 4 |
Microsoft
MSFT
|
$243M |
| 5 |
Chevron
CVX
|
$225M |
Sector Composition
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.12% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3901
DaVita
DVA
$9.72B
| – | – |
-53,100
| Closed | -$2.88M |
|
|
DX
3902
Dynex Capital
DX
$1.64B
| – | – |
-966,500
| Closed | -$5.89M |
|
3903
WisdomTree Japan Hedged Equity Fund
DXJ
$3.72B
| – | – |
-29,300
| Closed | -$1.48M |
|
3904
Editas Medicine
EDIT
$225M
| – | – |
-371,400
| Closed | -$9.08M |
|
3905
New Oriental
EDU
$7.98B
| – | – |
-286,300
| Closed | -$25.8M |
|
3906
Euronet Worldwide
EEFT
$3.72B
| – | – |
-271,245
| Closed | -$38.7M |
|
3907
iShares MSCI EAFE ETF
EFA
$65.4B
| – | – |
-42,700
| Closed | -$2.77M |
|
3908
iShares MSCI Indonesia ETF
EIDO
$331M
| – | – |
-41,706
| Closed | -$1.07M |
|
3909
Elevance Health
ELV
$72.4B
| – | – |
-275,973
| Closed | -$79.2M |
|
3910
Eastman Chemical
EMN
$7.76B
| – | – |
-50,940
| Closed | -$3.87M |
|
3911
Energizer
ENR
$1.94B
| – | – |
-401,020
| Closed | -$18M |
|
3912
iShares MSCI Peru and Global Exposure ETF
EPU
$174M
| – | – |
-7,000
| Closed | -$275K |
|